semaglutide and alcohol use disorder Could GLP-1 medications help transform treatment for addiction? Alcohol affects millions, yet there haven't been any new medications approved to treat it in 20 years. Now, new #CUAnschutz research While only three medications have

Mind-Body Medicine and Integrative Physiology Mind-body and complementary medicine applies to the same signaling systems through non-pharmacological means such as meditative practices, dietary changes, exercise, and social behavior

It is estimated that approximately 6% of men report non-medical testosterone use ( Studies conducted among strength athletes and bodybuilders have consistently demonstrated high rates of anabolicandrogenic substance use

Presented for research literature review only Heller W et al

These stories and data prove Med Matrixs approach works

This activation mobilizes stored triglycerides within hepatocytes for oxidation, effectively decreasing hepatic lipid content ( de novo lipogenesis while promoting lipid catabolism, resulting in a net reduction of hepatic steatosis ( In summary, this dual mechanism addresses the fundamental lipid dysregulation in MASLD by restoring the balance between lipid synthesis and degradation within the liver, thereby mitigating steatosis and its metabolic consequences ( 3.2.3 Anti-inflammatory and anti-fibrotic effects Activation of GLP-1 receptors by dual agonists exerts potent anti-inflammatory effects within the liver microenvironment, which are crucial for preventing progression from steatosis to steatohepatitis and fibrosis

Example: Ozempic